Medicare guidance endangers transplant patients' organs.

Medicare's new guidance on billing for post-transplant care is causing delays and confusion, putting the health of transplant patients at risk. Patients are unable to receive necessary tests and monitoring, leaving them vulnerable to infections and organ rejection. This is particularly concerning for patients who have already had multiple transplants and may not be eligible for another one if their current organ fails.